{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:08:21Z","timestamp":1790633301073,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH","award":["R01 CA186107"],"award-info":[{"award-number":["R01 CA186107"]}]},{"name":"NIH","award":["R01 CA97396"],"award-info":[{"award-number":["R01 CA97396"]}]},{"name":"NIH","award":["R01 CA207369"],"award-info":[{"award-number":["R01 CA207369"]}]},{"name":"Australian National Health and Medical Research Council","award":["209057"],"award-info":[{"award-number":["209057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-024-01922-6","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T12:01:03Z","timestamp":1732622463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Plasma prolactin and postmenopausal breast cancer risk: a pooled analysis of four prospective cohort studies"],"prefix":"10.1186","volume":"26","author":[{"given":"Jacob K.","family":"Kresovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Guranich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maegan E.","family":"Boutot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitch","family":"Dowsett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Heather","family":"Eliassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Garcia-Closas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minouk J.","family":"Schoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley S.","family":"Tworoger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine M.","family":"Vachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"1922_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2001-0036","volume":"24","author":"CV Clevenger","year":"2003","unstructured":"Clevenger CV, Furth PA, Hankinson SE, et al. The role of prolactin in mammary carcinoma. Endocr Rev. 2003;24:1\u201327.","journal-title":"Endocr Rev"},{"key":"1922_CR2","doi-asserted-by":"publisher","first-page":"910978","DOI":"10.3389\/fendo.2022.910978","volume":"13","author":"LA Schuler","year":"2022","unstructured":"Schuler LA, O\u2019Leary KA. Prolactin: the third hormone in breast Cancer. Front Endocrinol (Lausanne). 2022;13:910978.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1922_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1385\/ENDO:20:1-2:111","volume":"20","author":"MJ Naylor","year":"2003","unstructured":"Naylor MJ, Lockefeer JA, Horseman ND, et al. Prolactin regulates mammary epithelial cell proliferation via autocrine\/paracrine mechanism. Endocrine. 2003;20:111\u20134.","journal-title":"Endocrine"},{"key":"1922_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/mend.16.1.0762","volume":"16","author":"MD Schroeder","year":"2002","unstructured":"Schroeder MD, Symowicz J, Schuler LA. PRL modulates cell cycle regulators in mammary tumor epithelial cells. Mol Endocrinol. 2002;16:45\u201357.","journal-title":"Mol Endocrinol"},{"key":"1922_CR5","first-page":"509","volume":"26","author":"P Chakravarti","year":"2005","unstructured":"Chakravarti P, Henry MK, Quelle FW. Prolactin and heregulin override DNA damage-induced growth arrest and promote phosphatidylinositol-3 kinase-dependent proliferation in breast cancer cells. Int J Oncol. 2005;26:509\u201314.","journal-title":"Int J Oncol"},{"key":"1922_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1023\/A:1023956223037","volume":"79","author":"K Liby","year":"2003","unstructured":"Liby K, Neltner B, Mohamet L, et al. Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth. Breast Cancer Res Treat. 2003;79:241\u201352.","journal-title":"Breast Cancer Res Treat"},{"key":"1922_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jsbmb.2003.10.008","volume":"88","author":"JH Gutzman","year":"2004","unstructured":"Gutzman JH, Miller KK, Schuler LA. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells. J Steroid Biochem Mol Biol. 2004;88:69\u201377.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1922_CR8","first-page":"2591","volume":"55","author":"E Ginsburg","year":"1995","unstructured":"Ginsburg E, Vonderhaar BK. Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 1995;55:2591\u20135.","journal-title":"Cancer Res"},{"key":"1922_CR9","first-page":"3583","volume":"5","author":"WY Chen","year":"1999","unstructured":"Chen WY, Ramamoorthy P, Chen N, et al. A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis. Clin Cancer Res. 1999;5:3583\u201393.","journal-title":"Clin Cancer Res"},{"key":"1922_CR10","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1038\/sj.onc.1203846","volume":"19","author":"M Llovera","year":"2000","unstructured":"Llovera M, Pichard C, Bernichtein S, et al. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Oncogene. 2000;19:4695\u2013705.","journal-title":"Oncogene"},{"key":"1922_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/sj.bjc.6601947","volume":"91","author":"CM Perks","year":"2004","unstructured":"Perks CM, Keith AJ, Goodhew KL, et al. Prolactin acts as a potent survival factor for human breast cancer cell lines. Br J Cancer. 2004;91:305\u201311.","journal-title":"Br J Cancer"},{"key":"1922_CR12","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/sj.bjc.6600537","volume":"87","author":"NF Boyd","year":"2002","unstructured":"Boyd NF, Stone J, Martin LJ, et al. The association of breast mitogens with mammographic densities. Br J Cancer. 2002;87:876\u201382.","journal-title":"Br J Cancer"},{"key":"1922_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10549-006-9454-y","volume":"105","author":"GA Greendale","year":"2007","unstructured":"Greendale GA, Huang MH, Ursin G, et al. Serum prolactin levels are positively associated with mammographic density in postmenopausal women. Breast Cancer Res Treat. 2007;105:337\u201346.","journal-title":"Breast Cancer Res Treat"},{"key":"1922_CR14","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/ijc.22482","volume":"120","author":"AH Eliassen","year":"2007","unstructured":"Eliassen AH, Tworoger SS, Hankinson SE. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women. Int J Cancer. 2007;120:1536\u201341.","journal-title":"Int J Cancer"},{"key":"1922_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/bjc.1981.121","volume":"43","author":"MC Yu","year":"1981","unstructured":"Yu MC, Gerkins VR, Henderson BE, et al. Elevated levels of prolactin in nulliparous women. Br J Cancer. 1981;43:826\u201331.","journal-title":"Br J Cancer"},{"key":"1922_CR16","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1158\/1055-9965.EPI-14-0613","volume":"23","author":"K Tikk","year":"2014","unstructured":"Tikk K, Sookthai D, Johnson T, et al. Prolactin determinants in healthy women: a large cross-sectional study within the EPIC cohort. Cancer Epidemiol Biomarkers Prev. 2014;23:2532\u201342.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1922_CR17","doi-asserted-by":"publisher","first-page":"pky055","DOI":"10.1093\/jncics\/pky055","volume":"2","author":"M Gabrielson","year":"2018","unstructured":"Gabrielson M, Ubhayasekera K, Ek B, et al. Inclusion of plasma prolactin levels in current risk prediction models of premenopausal and postmenopausal breast Cancer. JNCI Cancer Spectr. 2018;2:pky055.","journal-title":"JNCI Cancer Spectr"},{"key":"1922_CR18","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1200\/JCO.2006.07.6356","volume":"25","author":"SS Tworoger","year":"2007","unstructured":"Tworoger SS, Eliassen AH, Sluss P, et al. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol. 2007;25:1482\u20138.","journal-title":"J Clin Oncol"},{"key":"1922_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13058-015-0563-6","volume":"17","author":"K Tikk","year":"2015","unstructured":"Tikk K, Sookthai D, Fortner RT, et al. Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study. Breast Cancer Res. 2015;17:49.","journal-title":"Breast Cancer Res"},{"key":"1922_CR20","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1093\/annonc\/mdu150","volume":"25","author":"K Tikk","year":"2014","unstructured":"Tikk K, Sookthai D, Johnson T, et al. Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort. Ann Oncol. 2014;25:1422\u20138.","journal-title":"Ann Oncol"},{"key":"1922_CR21","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-13-0665","volume":"73","author":"SS Tworoger","year":"2013","unstructured":"Tworoger SS, Eliassen AH, Zhang X, et al. A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Res. 2013;73:4810\u20139.","journal-title":"Cancer Res"},{"key":"1922_CR22","doi-asserted-by":"publisher","first-page":"25998","DOI":"10.1038\/srep25998","volume":"6","author":"M Wang","year":"2016","unstructured":"Wang M, Wu X, Chai F, et al. Plasma prolactin and breast cancer risk: a meta- analysis. Sci Rep. 2016;6:25998.","journal-title":"Sci Rep"},{"key":"1922_CR23","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-05-3369","volume":"66","author":"SS Tworoger","year":"2006","unstructured":"Tworoger SS, Sluss P, Hankinson SE. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res. 2006;66:2476\u201382.","journal-title":"Cancer Res"},{"key":"1922_CR24","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1158\/0008-5472.CAN-04-1870","volume":"64","author":"SS Tworoger","year":"2004","unstructured":"Tworoger SS, Eliassen AH, Rosner B, et al. Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res. 2004;64:6814\u20139.","journal-title":"Cancer Res"},{"key":"1922_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13058-023-01618-3","volume":"25","author":"CA Hathaway","year":"2023","unstructured":"Hathaway CA, Rice MS, Collins LC, et al. Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers. Breast Cancer Res. 2023;25:24.","journal-title":"Breast Cancer Res"},{"key":"1922_CR26","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1088\/0031-9155\/39\/10\/008","volume":"39","author":"JW Byng","year":"1994","unstructured":"Byng JW, Boyd NF, Fishell E, et al. The quantitative analysis of mammographic densities. Phys Med Biol. 1994;39:1629\u201338.","journal-title":"Phys Med Biol"},{"key":"1922_CR27","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1186\/bcr3570","volume":"15","author":"KA Bertrand","year":"2013","unstructured":"Bertrand KA, Tamimi RM, Scott CG, et al. Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res. 2013;15:R104.","journal-title":"Breast Cancer Res"},{"key":"1922_CR28","unstructured":"Mavaddat N, Michailidou K, Dennis J et al. Polygenic risk scores for prediction of breast Cancer and breast Cancer subtypes. Am J Hum Genet, 2018."},{"key":"1922_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/aje\/kwm348","volume":"167","author":"B Rosner","year":"2008","unstructured":"Rosner B, Cook N, Portman R, et al. Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol. 2008;167:653\u201366.","journal-title":"Am J Epidemiol"},{"key":"1922_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/00401706.1983.10487848","volume":"25","author":"B Rosner","year":"1983","unstructured":"Rosner B. Percentage points for a generalized Esd many-outlier Procedure. Technometrics. 1983;25:165\u201372.","journal-title":"Technometrics"},{"key":"1922_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1\u201367.","journal-title":"J Stat Softw"},{"key":"1922_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/ije\/21.2.214","volume":"21","author":"DY Wang","year":"1992","unstructured":"Wang DY, De Stavola BL, Bulbrook RD, et al. Relationship of blood prolactin levels and the risk of subsequent breast cancer. Int J Epidemiol. 1992;21:214\u201321.","journal-title":"Int J Epidemiol"},{"key":"1922_CR33","first-page":"79","volume":"18","author":"KJ Helzlsouer","year":"1994","unstructured":"Helzlsouer KJ, Alberg AJ, Bush TL, et al. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev. 1994;18:79\u201385.","journal-title":"Cancer Detect Prev"},{"key":"1922_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1023\/A:1025671317220","volume":"14","author":"J Manjer","year":"2003","unstructured":"Manjer J, Johansson R, Berglund G, et al. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes Control. 2003;14:599\u2013607.","journal-title":"Cancer Causes Control"},{"key":"1922_CR35","first-page":"575","volume":"9","author":"M Kabuto","year":"2000","unstructured":"Kabuto M, Akiba S, Stevens RG, et al. A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev. 2000;9:575\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1922_CR36","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/oby.2006.191","volume":"14","author":"A McTiernan","year":"2006","unstructured":"McTiernan A, Wu L, Chen C, et al. Relation of BMI and physical activity to sex hormones in postmenopausal women. Obes (Silver Spring). 2006;14:1662\u201377.","journal-title":"Obes (Silver Spring)"},{"key":"1922_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jsbmb.2017.04.011","volume":"176","author":"KA Leehy","year":"2018","unstructured":"Leehy KA, Truong TH, Mauro LJ, et al. Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models. J Steroid Biochem Mol Biol. 2018;176:88\u201393.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1922_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mce.2011.09.020","volume":"357","author":"HJ Lee","year":"2012","unstructured":"Lee HJ, Ormandy CJ. Interplay between progesterone and prolactin in mammary development and implications for breast cancer. Mol Cell Endocrinol. 2012;357:101\u20137.","journal-title":"Mol Cell Endocrinol"},{"key":"1922_CR39","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1463-1326.2006.00671.x","volume":"9","author":"T Brandebourg","year":"2007","unstructured":"Brandebourg T, Hugo E, Ben-Jonathan N. Adipocyte prolactin: regulation of release and putative functions. Diabetes Obes Metab. 2007;9:464\u201376.","journal-title":"Diabetes Obes Metab"},{"key":"1922_CR40","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1210\/jcem.85.3.6355","volume":"85","author":"RH Straub","year":"2000","unstructured":"Straub RH, Hense HW, Andus T, et al. Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J Clin Endocrinol Metab. 2000;85:1340\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"1922_CR41","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1158\/1055-9965.EPI-05-0848","volume":"15","author":"SA Missmer","year":"2006","unstructured":"Missmer SA, Spiegelman D, Bertone-Johnson ER, et al. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev. 2006;15:972\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1922_CR42","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s10549-012-2391-z","volume":"137","author":"X Zhang","year":"2013","unstructured":"Zhang X, Tworoger SS, Eliassen AH, et al. Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat. 2013;137:883\u201392.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-024-01922-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-024-01922-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-024-01922-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T13:06:10Z","timestamp":1732626370000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-024-01922-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1922"],"URL":"https:\/\/doi.org\/10.1186\/s13058-024-01922-6","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}